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Germline loss-of-function variation in TNFAIP3, encoding A20, has been implicated in a wide variety 
of autoinflammatory and autoimmune conditions, with acquired somatic missense mutations linked 
to cancer progression. Furthermore, human sequence data reveals that the A20 locus contains ~ 400 
non-synonymous coding variants, which are largely uncharacterised. The growing number of A20 
coding variants with unknown function, but potential clinical impact, poses a challenge to traditional 
mouse-based approaches. Here we report the development of a novel functional genomics approach 
that utilizes a new A20-deficient zebrafish (Danio rerio) model to investigate the impact of TNFAIP3 
genetic variants in vivo. A20-deficient zebrafish are hyper-responsive to microbial immune activation 
and exhibit spontaneous early lethality. Ectopic addition of human A20 rescued A20-null zebrafish 
from lethality, while missense mutations at two conserved A20 residues, S381A and C243Y, reversed 
this protective effect. Ser381 represents a phosphorylation site important for enhancing A20 activity 
that is abrogated by its mutation to alanine, or by a causal C243Y mutation that triggers human 
autoimmune disease. These data reveal an evolutionarily conserved role for TNFAIP3 in limiting 
inflammation in the vertebrate linage and show how this function is controlled by phosphorylation. 
They also demonstrate how a zebrafish functional genomics pipeline can be utilized to investigate the 
in vivo significance of medically relevant human TNFAIP3 gene variants.
In mammals, the cytoplasmic ubiquitin-editing enzyme A20, encoded by the TNFAIP3 gene, plays a key role in 
maintaining inflammatory  homeostasis1 mediated by its function to inhibit NF-κB  activation2–6. The medical 
importance of A20’s role in dampening NF-κB is highlighted by cases of germline A20 loss-of-function mutations 
in humans who present with severe autoinflammatory  disease7,8, and by the impact of A20 deletion in mice, which 
results in spontaneous and widespread NF-κB activation, multi-organ inflammation and premature  lethality1,9. 
The emergence of A20 mutations and coding variants as causal genetic factors driving human  disease10,11 high-
light the need to understand the functional domains of A20 that control inflammation in vivo.
A20 suppresses NF-κB signalling with inhibitory activity against key signalling molecular substrates, including 
TNF receptor-associated factor 6 (TRAF6)9, receptor interacting protein 1 (RIP1)12,13, and the IκB kinase complex 
(IKK)14. The A20 ovarian-tumour (OTU) domain exhibits deubiquitinating editing (DUB) activity centred on 
Cys103, which cleaves activating K63-linked ubiquitin chains from RIPK1, TRAF6 and NEMO to terminate 
NF-κB  signalling9,12,13,15. The A20 zinc finger 4 (ZnF4) exhibits E3 ligase activity, adding K48-linked ubiquitin 
chains to RIPK1, triggering RIPK1  proteolysis12,16. In addition, the C-terminal ZnF7 domain of A20 binds lin-
ear ubiquitin to non-catalytically suppress NF-κB  activity17. A20 is regulated at the level of gene  transcription6, 
whereby NF-κB activation induces TNFAIP3  expression18,19 forming a negative feedback loop, and the inhibitory 
activities of A20 enzymatic sites are enhanced by IKKB-mediated serine phosphorylation at  Ser38120,21.
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We have previously shown that coding variants that impair A20 Ser381  phosphorylation13, and thereby reduce 
the activity of both enzymatic Cys103 and ZnF4 domains of  A2012,13,20, exhibited a much larger in vivo effect in 
mice than mutations that disable the individual enzymatic sites Cys103 and  ZnF413,21,22. These data point towards 
an important role for non-catalytic Ser381 in regulating A20’s anti-inflammatory activity in vivo, however, the 
in vivo impact of deleting Ser381 has not been tested.
The importance of A20 in human disease, as well as the emerging functional complexities highlighted by 
experimental studies examining A20  mutations13, coupled with the discovery of new TNFAIP3 coding variants 
from human genome sequencing studies (e.g. gnomAD) demonstrate the need for novel approaches to investigate 
A20 functional domains. We hypothesized that elucidation of A20’s conserved regions across additional species 
may aid the resolution of protein domains of relevance to human disease. Here we report the development of a 
novel functional genomics pipeline that utilizes the new A20-deficient zebrafish (Danio rerio) model to investigate 
the impact of TNFAIP3 genetic variants in vivo. We show that A20 is essential for the maintenance of immune 
homeostasis and survival in zebrafish, demonstrating functionally that the emergence of A20 was essential for 
regulation of microbial sensing at an early junction in vertebrate evolution. Further, using this zebrafish para-
digm we demonstrate how a zebrafish functional genomics approach can be utilized to investigate the in vivo 
significance of human TNFAIP3 gene variants. These latter studies reveal how phosphorylation regulates A20’s 
evolutionary conserved anti-inflammatory activity in vivo.
Results
Genomic analysis of the zebrafish tnfaip3 locus. Many of the mammalian components of the NF-κB 
signalling  system23,24 and innate  immunity25,26 are conserved in zebrafish making this animal model a candidate 
in vivo paradigm for the analysis of A20’s key functional regions. This concept was further supported by analysis 
of zebrafish genomic data which revealed gene order preservation of the TNFAIP3 locus with OLIG3 and PERP 
in zebrafish (Supplementary Fig. S1A), and a conserved and easily identifiable Topologically Associating Domain 
(TADs) overlapping with A20 and highly enriched in the regulatory histone mark H3K27ac (histone 3, lysine 27 
acetylation) (Supplementary Fig. S1B), a hallmark of active promoters and  enhancers27,28. Furthermore, some 
of these conserved H3K27c marked regions overlapped with the positions of A20 SNPs identified in human 
genome wide association studies (GWAS) to be linked with Crohn’s disease and Systemic lupus erythematosus 
(Supplementary Fig. S1A). The tnfaip3 zebrafish  orthologue26 encoded a predicted 762 amino acid polypep-
tide comprising an N-terminal ovarian tumour (OTU) domain (identity score of 94/100), including the puta-
tive catalytic cysteine at position 103 in A20’s OTU  domain29, and seven zinc finger regions in the C-terminus 
(identity scores of 79/100) (Supplementary Fig. S2). The zebrafish A20 C-terminal domain also contained zinc 
finger 4 (ZnF4) and ZnF7 regions, which showed multiple sequence alignment scores of 91/100 and 100/100, 
respectively, and are thus highly homologous to functional ZnF4 and ZnF7 domains identified in mammalian 
 studies17,21. In mammalian cells A20 expression is controlled at the level of transcription by the NF-κB pathway 
in response to microbial stimulation of  TLR19, a pathway that represents a key component of innate immunity 
conserved in  zebrafish30. Stimulation of cultured zebrafish embryos 3 days post-fertilization (dpf) with 75 µg/ml 
of the gram-negative bacteria product lipopolysaccharide (LPS) also resulted in the rapid induction of zebrafish 
(zf) zfA20 (tnfaip3) mRNA as well as TNF (tnf), zfIL-1beta (il1b) and zfIL-6 (il6) mRNA (Fig. 1A).
Generation of a zebrafish model of A20 deficiency. Because A20 deletion in zebrafish had not been 
previously reported, we utilized site directed transcription activator-like effector nucleases (TALEN) to intro-
duce a disabling mutation within exon 2 of the zebrafish A20 locus (Fig. 1B). A zebrafish line was identified that 
showed a 20 bp deletion in the tnfaip3 sequence which was predicted to introduce a premature truncation at 
amino acid 127  (tnfaip3gi3, hereafter  A20∆127). Heterozygous  A20∆127 zebrafish were bred to homozygosity and 
deletion of A20 was confirmed in offspring by high-resolution melting assay (HRMA), Sanger sequencing, and 
analysis of PCR products that differentiate A20 wild-type alleles from  A20+/∆127, and  A20∆127/∆127 (Supplemen-
tary Fig.  S3A–C). Heterozygous  A20∆127 zebrafish were mated to generate  A20+/+,  A20+/∆127, and  A20∆127/∆127 
zebrafish.
Figure 1.  A20-deficient zebrafish fail to thrive. (A) Peak induction of inflammatory genes, and relative p-values. 
*P < 0.05, **P < 0.01. (B) Gene targeting of A20 highlighting the 20 bp deletion and predicted stop codon at 
amino acid 127, previously a Leucine. (C) Percentages of surviving  A20+/+,  A20+/∆127 and  A20∆127/∆127 zebrafish at 
1, 2, 3 and 8wpf, generated from N = 15  A20+/∆127 crosses. (D) Body area measured in (pixel/inch) per zebrafish 
genotype at 1 and 2 wpf. Each dot represents an individual zebrafish. Data represented as mean ± SD, P-values 
were determined using 1way ANOVA. ****P < 0.0001. Each group passed the normality test. (E) Representative 
brightfield image of one  A20+/+ (top) and  A20∆127/∆127 (bottom) zebrafish at 2 wpf. Scale bar represent 2 mm. 
(F) Liver to body ratios measured in (pixel/inch) per zebrafish genotype at 1 and 2 wpf. Each dot represents an 
individual zebrafish. Data represented as mean ± SD, P-values were determined using 1way ANOVA. **P < 0.01, 
****P < 0.0001. Each group passed the normality test. For each genotype a representative  A20+/+,  A20+/∆127 and 
 A20∆127/∆127 2 wpf zebrafish is shown. The scale bars represent 2 mm. (G) Immuno-fluorescence sections of livers 
from 2CLIP reporter fish for the A20 genotypes. The scale bars represent 300 μm. Software used for this Figure: 
GraphPad Prism v7.0 (https ://www.graph pad.com/scien tific -softw are/prism /), Adobe Illustrator CC 2018 (https 
://www.adobe .com/au/produ cts/illus trato r.html), Leica LAS X (https ://www.leica -micro syste ms.com/produ cts/
micro scope -softw are/p/leica -appli catio n-suite /), IMARIS Image Analysis Software v8 (BITPLANE, Switzerland) 
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A20 deficiency is lethal in zebrafish. To validate the use of A20 deficient zebrafish for testing human 
A20 variants, we investigated the impact of zebrafish A20 deletion with respect to sentinel A20 phenotypes 
reported in mammals. The key mouse phenotype is premature  lethality1 but also reported in the literature are 
loss of organ homeostasis, gross anatomical changes (i.e. runting), as well as hyper-responsiveness to TLR-
induced NF-κB activity and heightened macrophage  activity9,31. Accordingly,  A20+/+,  A20+/∆127, and  A20∆127/∆127 
zebrafish were followed through time to assess survival.  A20∆127/∆127 zebrafish presented in the expected Mende-
lian ratios at 1 week post-fertilization (wpf), however, by 2wpf zebrafish homozygous for A20 deletion presented 
with premature lethality and no  A20∆127/∆127 zebrafish survived to three weeks post-fertilization (Fig. 1C). Many 
 A20∆127/∆127 zebrafish also exhibited gross abnormalities including reduced body size (Fig. 1D) and evident mal-
formations of the torso (Fig. 1E). Similar to mice heterozygous for A20  deletion1,  A20+/∆127 zebrafish were viable 
and showed no gross phenotype or lethality (Fig. 1C). Mice lacking A20 present with a rapid and early onset 
of systemic inflammation of the organs particularly the  liver1. To examine the impact of A20 deletion upon 
organ homeostasis A20 deficient zebrafish were crossed with 2-Color Liver Insulin acinar Pancreas (2CLIP) 
zebrafish, which express dsRed fluorescent protein driven by the fatty acid binding protein 10 (fabp10) promoter 
in  hepatocytes32.  A20∆127/∆127:2CLIP zebrafish are phenotypically runted but also show a marked reduction in 
liver area to their body size when compared to WT zebrafish (Fig. 1F). Reduction in liver size was not due to a 
developmental defect as liver size was normal in 1 wpf  A20∆127/∆127:2CLIP zebrafish. Confocal analysis of 2wpf 
 A20∆127/∆127:2CLIP zebrafish livers (Fig. 1G), as well as 3-D rendering of the liver (Supplementary Videos S1 and 
S2), revealed a reduction in liver cellularity, and an increase in caspase-3 positive hepatocytes. We interpret these 
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Figure 2.  A20 is necessary to maintain inflammatory homeostasis in zebrafish. (A) Representative fluorescent 
image of a NF-κB:EGFP zebrafish at 6 dpf showing spontaneous NF-κB activity (fluorescence) in the (a) mouth, 
(b) lateral neuronmasts, (c) pharyngeal tooth, and (d) gills. Scale bar represents 2 mm. (B) Representative 
fluorescent images of NF-κB:EGFP zebrafish of different A20 genotypes at 3 and 6 dpf ± LPS. The scale bars 
represent 1 mm. (C, D) Cumulative data of relative fluorescence units of NF-κB:EGFP zebrafish by A20 
genotype at; 3 dpf without LPS stimulation and 6 dpf ± LPS. Each dot represents an individual fish. Data are 
representative of N = 10 crosses. N per group and mean values reported below each graph. Data represented as 
mean ± SD, P-values were determined using 1-way ANOVA. Each group passed the normality test. **P < 0.01, 
***P < 0.001, ****P < 0.0001. Software used for this Figure: GraphPad Prism v7.0 (https ://www.graph pad.com/
scien tific -softw are/prism /), Adobe Illustrator CC 2018 (https ://www.adobe .com/au/produ cts/illus trato r.html), 
Leica LAS X (https ://www.leica -micro syste ms.com/produ cts/micro scope -softw are/p/leica -appli catio n-suite /).
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A20 limits NF-κB activation in zebrafish. Mice deficient for A20 are hyper-responsiveness to TLR-
induced NF-κB  activation9,31. To investigate NF-κB activation in A20 deficient zebrafish, we generated a trans-
genic zebrafish reporter line expressing green fluorescent protein (EGFP) under transcriptional control of a 
NF-κB promoter element (NF-κB:EGFP) and crossed these to  A20+/∆127 zebrafish. The spontaneous responsive-
ness of NF-κB activation in zebrafish in vivo is a direct result of colonization by environmental  microbiota24. As 
shown in Fig. 2A,B, on a wild type background the NF-κB:EGFP reporter demonstrates spontaneous activation. 
NF-κB driven fluorescence was found to be at its highest expression in those tissues that mostly interact with the 
external environment, namely the mouth, neuromasts, pharyngeal tooth, gills and gut (Fig. 2A). Also, NF-κB 
driven fluorescence increased through time (compare 3dpf  A20+/+ zebrafish with 6dpf; Fig. 2B,C) most likely 
reflecting exposure to environmental  microbiota24, and this was increased further in  A20+/∆127 and  A20∆127/∆127 
zebrafish in a gene dose manner (Fig.  2D). Furthermore, the addition of LPS to zebrafish embryos further 
enhanced NF-κB activation and this was most pronounced in  A20∆127/∆127 zebrafish (Fig. 2D).
Zebrafish A20-deficient macrophages are hyper-responsive to inflammatory triggers. A20 
loss of function mutations result in macrophage hyper responsiveness to microbial stimulation and sponta-
neous inflammasome  activation9,13,17. Tissue macrophages play a key role in sensing pathogenic microbiota 
in zebrafish. To investigate the impact of A20 deletion on macrophage homeostasis, heterozygous  A20+/∆127 
zebrafish were crossed to a macrophage reporter line whereby RFP is expressed under the control of the promo-
tor of macrophage-expressed gene 1.1 (mpeg1.1). The number of macrophages detected in the skin was ~ 2- to 
4-fold higher in  A20∆127/∆127 zebrafish when compared to their wild type counterparts (Fig. 3A,B). We also cre-
ated a  A20∆127/∆127 T cell reporter line whereby RFP is expressed under the control of the lymphocyte-specific 
protein tyrosine kinase promotor lck, this reporter line showed that A20 deletion also led to increased num-
bers of dermal T cells (Fig. 3C,D). In addition to increased numbers, the majority of dermal macrophages in 
 A20∆127/∆127 zebrafish exhibited dendritic extensions (Fig. 3A magnification) indicative of an activated  state33,34. 
Imaging of double reporter (NF-κB:EGFP x mpeg1.1:RFP) WT zebrafish by two-photon microscopy (Fig. 3E, 
Supplementary Video S3) showed co-localisation of NF-κB activation with MPEG1 reporter expression further 
highlighting activation of dermal macrophages in  A20∆127/∆127 zebrafish. This was also made further apparent by 
histological analysis through transverse sections of the cranium, which revealed dense infiltration of mpeg1.1 
positive cells close to the dermal surface (Supplementary Fig. S4). From these cranial sections it could be seen 
that the position of the mpeg1.1 positive cells corresponded with cells at the dermal surface exhibiting bright 
NF-κB:EGFP reporter activity.
Recruitment to sites of inflammation constitute important physiological roles for the macrophage immune 
compartment. Using a tail clip wound  model35 we found that both  A20+/∆127 and  A20∆127/∆127 zebrafish showed 
an increased recruitment of macrophages at the wound interface through time (Fig. 3F). Interestingly, this 
analysis revealed a macrophage phenotype for heterozygous  A20+/∆127 zebrafish post challenge whereas we did 
not observe a change in  A20+/∆127 macrophage numbers in the steady state (Fig. 3B). To investigate this further, 
we used two-photon imaging of single mpeg1.1:RFP reporter  A20+/∆127 zebrafish to track individual macrophage 
cell movement in vivo in real time (Fig. 3G,H, supplemented by Supplementary Video S4). This analysis revealed 
that  A20+/∆127 macrophages exhibited increased cell movement in the steady state (track length:displacement 
ratio = 3.95 for WT macrophages versus 4.55 for  A20+/∆127 macrophages), and was attributed to increases in track 
speed, track displacement and track length (Fig. 3H).
Human A20 rescues  A20∆127/∆127 zebrafish from lethality. The phenotypic similarities between 
A20-deficient zebrafish and those reported for A20-deficient  mice1,9,17, as well as the profound inflammatory 
syndromes reported for human subjects with heterozygous A20  deficiency8, supported utilizing zebrafish as 
a model organism to investigate the role of A20 protein domains in regulating its function in  vivo. For our 
functional analysis pipeline, we determined that rescue of  A20∆127/∆127 zebrafish from lethality would provide 
the most robust readout for loss or gain of function phenotypes in various A20 genetic variants. For the func-
tional analysis, zebrafish eggs derived from  A20+/∆127 × A20+/∆127 crosses were ectopically injected with wild-type 
human (h)A20 expressed in the construct Ubb-hA20-P2A-EGFP that also expresses GFP. The low integration 
Ubb-hA20-P2A-EGFP construct was chosen to limit potential off-target effects as well as false  positives36–38. The 
zebrafish eggs were injected in a blinded fashion with the Ubb-hA20-P2A-EGFP construct and were assessed 
for the presence of GFP fluorescence (Supplementary Fig. S5A). Human A20 expression in injected embryos 
was confirmed by mRNA analysis (Supplementary Fig. S5B). At 1 wpf  A20∆127/∆127 zebrafish presented in the 
expected mendelian ratio of ~ 25% of genotypes (Fig. 1C) but later exhibited a highly penetrant lethal pheno-
type with no survivors at 3wpf (Fig. 4A). In contrast, with ectopic expression of hA20,  A20∆127/∆127 zebrafish 
now comprised 9.91% of the total of all genotypes at 3wpf (Fig. 4A). Further, all surviving  A20∆127/∆127 zebrafish 
were positive for EGFP expression derived from the Ubb-hA20-P2A-EGFP construct (Supplementary Fig. S5C). 
Given an expected Mendelian ratio of 25%, ectopic expression of hA20 rescued ~ 40% of  A20∆127/∆127 zebrafish 
from lethality highlighting the strong evolutionary conservation for A20’s function across the veterbrate lineage.
Alanine substitution of Ser381 and the human mutation C243Y impairs A20’s in vivo func-
tion. We previously demonstrated that a series of A20 coding variants, all within A20’s OTU domain, showed 
a strong correlation between a graded loss of A20’s NF-κB inhibitory function and an increasing hyper-inflam-
matory in vivo phenotype with reduced phosphorylation at  Ser38113. The coding variant C243Y which showed 
the strongest in vivo phenotype and caused the greatest reduction in Ser381 phosphorylation was originally 
identified in a four generation Japanese family with hereditary autoinflammatory  disease7. In vitro biochemical 
studies show that IκB kinase beta (IKKβ)-dependent phosphorylation at Ser381 is required for A20’s optimal 
6
Vol:.(1234567890)




















































































      N =        68               98       N =        68               98



































Scientific Reports |        (2020) 10:19085  | https://doi.org/10.1038/s41598-020-75917-6
www.nature.com/scientificreports/
NF-κB and JNK suppressive  function13,20,39 (Fig. 4B; Supplementary Fig. S5D,E). Both Ser381 and Cys243 are 
conserved in zebrafish (Supplementary Fig. S2) allowing us to test the impact of alanine substitution at Ser381, 
and the impact of the disease causing variant C243Y on the ability of human A20 to rescue  A20∆127/∆127 zebrafish 
from lethality.
As shown in Fig. 4A, ectopic injection of either S381A or C243Y expressing constructs into  A20∆127/∆127 
embryos rescued less fish from death compared to  A20∆127/∆127 embryos that received wild-type hA20-expressing 
constructs. Specificity for the impact of S381A and C243Y on A20’s in vivo function was shown by ectopic 
injection of another OTU domain mutant, namely the C103A DUB  mutant13,21,22, which niether impaired A20’s 
ability to rescue  A20∆127/∆127 embryos from lethality, nor A20’s ability to block NF-κB or JNK signalling in vitro 
(Fig. 4A,B; Supplementary Fig. S5D,E). The in vivo rescue properties of individual A20 mutants did not relate 
to differences in protein stability, as shown by Western blot analysis of A20 protein levels when expressed in cell 
lines (Fig. 4B)13, nor differences in the levels of transgene expression in vivo as measured by the levels of GFP 
fluorescence which is co-expressed with A20 in the Ubb-hA20-P2A-EGFP construct (Supplementary Fig. S5A).
Discussion
A20 inhibits NF-κB activation in mammals in response to TLR  signals1,9, and uncontrolled NF-κB activation 
results in excessive inflammation and  lethality40, yet there is little information regarding the in vivo functional 
role of A20 beyond mammalian models. An A20-like protein sequence has been identified in the purple sea 
urchin and  amphioxus41 and in the lamprey  genomes42 and here we identify a functional A20 homologue in 
zebrafish. In contrast, we did not find a homologous A20 sequence in the genomes of lower invertebrates includ-
ing Drosophila. Similar to mammalian cells, and as shown here for zebrafish, A20 expression in amphioxus is 
also regulated by  LPS19,41 and in both amphioxus and mammalian cells A20 modulates NF-κB signalling via a 
ubiquitin editing  function13,21,41. However, the in vivo functional significance of A20 in amphioxus has not been 
 tested41. Reminiscent of mouse  data1,9, we found that A20 deficiency in zebrafish resulted in spontaneous hyper-
responsiveness to environmental microbiota with early lethality. Remarkably re-introduction of human A20 
could rescue a proportion of A20-deficient zebrafish from lethality. These data highlight the strong functional 
evolutionary conservation for A20 in vertebrates, suggesting that A20 arose early during chordate evolution to 
regulate inflammatory homeostasis. As the major components of NF-κB signalling in mammals are conserved 
to Drosophila13,43 it is unclear as to why A20-dependent control of NF-κB signalling was required for chordate 
evolution, but further studies to investigate A20 function in the purple sea urchin would be informative. In 
mammalian cells A20 has been shown to regulate diverse signalling cascades that control inflammation and cell 
death in both hematopoietic and non-hematopoietic cell  lineages10,44. Further investigation of A20’s function in 
non-mammalian systems like zebrafish will reveal to what extent these critical mammalian functions extend to 
other vertebrates and aid our understanding of the evolutionary significance of A20.
Gene targeting in mice to either introduce an alanine at Cys103 (C103A) that eliminates biochemical OTU 
DUB  activity21, or a mutation that destroys the ZnF4 E3 ligase activity of  A2022, resulted in surprisingly little or 
no impact on lipopolysaccharide (LPS) responses and inflammatory homeostasis in vivo22,45, contrasting the 
lethal hyper-inflammatory phenotype of A20-deficient  mice1,9. These findings indicate compensatory activity 
of the Cys103 and ZnF4 catalytic domains towards each other, and redundancy in the mechanism by which the 
OTU domain regulates NF-κB activation, which may include both catalytic and non-catalytic  roles12,14. Previ-
ous biochemical studies have shown that A20’s NF-κB inhibitory activity requires phosphorylation at Ser381 
by IκB-kinase20,21. We previously provided evidence for the importance of Ser381 in vivo13. We demonstrated 
Figure 3.  Impact of A20 deletion on macrophage activity in zebrafish. (A) Representative fluorescent image 
of  A20+/+;mpeg1.1:RFP (top) and  A20∆127/∆127;mpeg1.1:RFP (bottom) zebrafish at 1 wpf. (B) Number of 
macrophages counted from images of zebrafish by A20 genotype as in (A). Data represented as mean ± SD, 
P-values were determined using Whelch’s t-test. ****P < 0.0001. (C) Representative fluorescent image 
of  A20+/+;lck:RFP (top) and  A20∆127/∆127;lck:RFP (bottom) zebrafish at 1 wpf. (D) Number of dermal T 
lymphocytes counted from images of zebrafish by A20 genotype as in (C). Data represented as mean ± SD, 
P-values were determined using Whelch’s t-test. ***P < 0.001, ****P < 0.0001. (E) 3-D rendering of a Two-
Photon microscope tilemap of a double-reporter (NF-κB:EGFP;mpeg1.1:RFP)  A20+/+ zebrafish. The image 
shows three channels: Collagen (in magenta) generated through Second Harmonic, NF-κB (in green) generated 
though EGFP fluorescence and mpeg1.1 (in red) generated through RFP fluorescence. The accompanying 
video (Supplementary Video S3) navigates through the 3D rendering. IMARIS Image Analysis Software v8 
(BITPLANE, Switzerland) (https ://imari s.oxins t.com/). (F) Average number of macrophages at the site of injury 
measured at 24 and 48 h post-injury. Error bands are SEM. Area under the curve at 24 hpi was significant for 
 A20+/+ x  A20+/∆127 (*p < 0.05) and  A20+/+ x  A20∆127/∆127 (*p < 0.05). (G) Screenshots of a Two-Photon z-stack 
15 min time-lapse track path of an  A20+/+;mpeg1.1:RFP and  A20∆127/∆127;mpeg1.1:RFP zebrafish in the resting 
state. The tracks show the path taken by a representative macrophage expressing RFP. The chosen macrophages 
are the closest to the average tracking data. (H) Macrophages from mpeg1.1:RFP positive zebrafish were imaged 
using in vivo two-photon microscopy and their track speed, track displacement and track length were quantified 
and used to determine a ‘meandering index’. Data collected from 4  A20+/+ and 3  A20+/∆127 comprising of 68 and 
98 macrophages tracks respectively. Data represented as mean ± SD, P-values were determined using Mann–
Whitney t-test. ****P < 0.0001. Software used for this Figure: GraphPad Prism v7.0 (https ://www.graph pad.com/
scien tific -softw are/prism /), Adobe Illustrator CC 2018 (https ://www.adobe .com/au/produ cts/illus trato r.html), 
Leica LAS X (https ://www.leica -micro syste ms.com/produ cts/micro scope -softw are/p/leica -appli catio n-suite /), 
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A20+/+ = 7 
A20+/∆127 = 9 
A20∆127/∆127 = 3
A20+/+ = 13 
A20+/∆127 = 24 
A20∆127/∆127 = 4
A20+/+ = 16
A20+/∆127 = 21 
A20∆127/∆127 = 3
A20+/+ = 24 
A20+/∆127 = 47 
A20∆127/∆127 = 5
A20+/+ = 5 
A20+/∆127 = 4 
A20∆127/∆127 = 1
A20+/+ = 7 
A20+/∆127 = 7 
A20∆127/∆127 = 2
A20+/+ = 18 
A20+/∆127 = 25 
A20∆127/∆127 = 2
A20+/+ = 7 
A20+/∆127 = 23 
A20∆127/∆127 = 8
A20+/+ = 5 
A20+/∆127 = 24 
A20∆127/∆127 = 0
A20+/+ = 8 
A20+/∆127 = 28 
A20∆127/∆127 = 4
A20+/+ = 18 
A20+/∆127 = 26
A20∆127/∆127 = 1






N =  162               176     230               109                157             106
A20+/+ = 20 
A20+/∆127 = 34 
A20∆127/∆127 = 0
A20+/+ = 8 












A20+/+ = 16 
A20+/∆127 = 22 
A20∆127/∆127 = 0
A20+/+ = 10 
A20+/∆127 = 12 
A20∆127/∆127 = 0






Figure 4.  The impact of human A20 mutants on  A20∆127/∆127 zebrafish survival. (A) Survival data for  A20+/+, 
 A20+/∆127 and  A20∆127/∆127 zebrafish at 3 wpf (zfA20), mock injected (Sham) or with ectopic administration of 
wild-type human A20  (hA20WT), C103A, S381A or C243Y mutants. Numbers indicate number of genotyped 
survivors expressing the respective human gene variant. Each box indicates the survivors from an independent 
experiment. Survival frequency data is represented in the pie chart. N indicates the total number of zebrafish 
embryos injected for each A20 mutant. Statistical difference was observed between zfA20 and C103A injected/
rescued fish (*p < 0.05) and between C103A and C243Y injected fish (*p < 0.05). (B) NF-κB luciferase assay for 
HEK293 cells transiently non-transfected (NTC), or co-transfected with wild-type human A20  (hA20WT) or the 
C103A, S381A or C243Y mutant and treated with or without hTNFα. Data represented as mean ± SD. P-values 
were determined using ANOVA. Each dot represents an individual experiment and are representative of N = 3–5 
experiments per A20 mutant. Below is shown a representative Western blot for each A20 mutant. The displayed 
gel has been cropped to improve clarity and conciseness of the figure. Software used for this Figure: GraphPad 
Prism v7.0 (https ://www.graph pad.com/scien tific -softw are/prism /), Adobe Illustrator CC 2018 (https ://www.
adobe .com/au/produ cts/illus trato r.html), Bio-rad ChemiDoc v6 (https ://www.bio-rad.com/en-au/produ ct/
chemi doc-imagi ng-syste m?ID=OI91X Q15).
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how a series of A20 coding variants that cause a decrease in phosphorylation at Ser381 also decrease A20’s 
NF-κB inhibitory activity in a graded manner, with a corresponding reduction in the ability of A20 to control 
inflammatory homeostasis in vivo. Such coding variants can have medical relevance, they may be beneficial by 
increasing protective immunity to  pathogens13, however increased tissue inflammation may also be detrimental 
in situations including autoimmune  disease7 and organ  transplantation46.
Here, using a new zebrafish functional genomics approach, we show evidence that Ser381 phosphorylation is 
needed for A20’s optimal anti-inflammatory function in vivo by directly targeting Ser381. Targeted mutation of 
Ser381 impaired the ability of A20 to rescue  A20∆127/∆127 zebrafish from lethality. Reduced Ser381 phosphoryla-
tion disables both the OTU DUB and ZnF4 ubiquitin editing functions of  A2013. This could explain the highly 
penetrant phenotype seen for both zebrafish and  mice13 carrying variants that impact Ser381 when compared 
to the relatively mild phenotypes observed in mice carrying mutations that disable the individual catalytic 
 domains22,45. Further studies are required to understand how phosphorylation at Ser381 impacts A20’s function 
but one possibility is that phosphorylation causes changes to A20 structure facilitating interactions between 
A20’s distinct ubiquitin binding and ubiquitin editing domains with ubiquitin. Indeed, two studies highlight 
the importance of ubiquitin binding domains (i.e. ZF4 and ZF7) in preventing inflammatory  disease47,48. We 
predict that access to ubiquitin by these domains is regulated by A20  phosphorylation13. Understanding how 
specific molecular changes in A20 effect function and cellular phenotypes may provide a pathway to understand 
the seemingly broad association of A20 to many different tissue specific autoimmune diseases identified through 
 GWAS10 and the broad clinical phenotypes emerging in patients identified with A20  haploinsufficiency41,49,50.
A20 deletion results in severe autoinflammatory disease in  humans31,49–52. The severe impact of mutating 
Ser381 on A20 function shown here, and the discovery of an ever-increasing number of new A20 coding variants 
through human sequencing  studies13, raise the question as to the existence of further human coding variants, 
which may present with highly penetrant phenotypes and contribute to disease. The conservation of A20 in 
zebrafish allows us to construct a functional genomics pipeline to investigate the impact of medically and scien-
tifically important human A20 coding variants in vivo. The discovery of the cysteine to tyrosine substitution at 
position 243 (C243Y) in a four generation Japanese family with a Behcet’s like  disease7, together with the high 
level of sequence homology across the mammalian and zebrafish OTU domains which included this residue, 
provided an opportunity to test the sensitivity of the zebrafish pipeline. In this zebrafish model the C243Y muta-
tion caused a reduction in A20’s ability to rescue homozygous A20-null zebrafish from lethality. This in vivo proof 
of concept data in the zebrafish model showing that C243Y is a reduction of function variant is supported by the 
human genetic  data7, as well as biochemical and mouse  data13. A20 variants like C243Y that modify phospho-
rylation at Ser381 therefore represent a novel class of variants with medically relevant disease-causing potential.
We highlight the potential of the zebrafish system to advance our knowledge of medically significant A20 gene 
variants by taking advantage of regions of high homology. In addition to shedding light on the functional signifi-
cance of A20 coding variants, the conservation of the zebrafish A20 genomic locus may also aid the elucidation 
of non-coding variants. GWAS studies associate A20 with multiple autoimmune conditions and many identi-
fied SNPs are non-coding10. Analysis of conserved trans regulatory regions in the A20 locus marked by active 
methylation marks revealed an overlap with two SNPs associated with Crohn’s disease (rs7753394; rs7773904) 
(GRCh38) and one associated with Systemic lupus erythematosus (rs10499197)53–55. As these SNP’s lay in putative 
enhancer regions, they may alter A20 expression levels thereby contributing to disease. The development of a 
novel functional genomics pipeline that utilizes A20-deficient zebrafish model provides a new tool to investigate 
the impact of TNFAIP3 genetic variants in vivo. Understanding the underlying genetic code of A20 will have 
relevance for understanding human disease mechanisms and the development of targeted drug therapies. This 
same approach could be utilized to increase understanding of the impact of human genetic variation for other 
highly conserved genes.
Materials and methods
Zebrafish. Fertilized eggs were collected from zebrafish (Danio rerio) group matings and incubated at 
28.5  °C at a density < 60 embryos in ~ 25 mL E3 egg water. Adult zebrafish were maintained under standard 
conditions at 28.5 °C and pH 7–8 at a density of 5–10 fish  L−1 under a photoperiodic cycle of 14/10 light/dark 
hours. Genotyping was performed by fin clipping and HotSHOT DNA  extraction56,57 followed by High Resolu-
tion Melting assay. Animal studies were approved by the Garvan/St Vincent’s Animal Ethics Committee. All 
procedures performed complied with the Australian Code of Practice for Care and Use of Animals for Scientific 
Purposes.
Genomic structure of A20. HiC data (40  Kb resolution) corresponding to H1 cells were visualized in 
the 3D genome  browser58 (hg19 genome assembly). Layered H3K27ac ChIP-seq data from seven cell lines 
(GM12878, H1-hESC, HSMM, HUVEC, K562, NHEK, NHLF), available through the UCSC genome  browser59 
were generated by the ENCODE consortium (2012). Zebrafish 24hpf embryo H3K27ac ChIP-seq reads were 
mapped by  Bowtie60 to unique genomic positions, followed by duplicate removal. Mapped ChIP-seq reads were 
visualized in WIG format as previously  described61 utilizing the UCSC genome browser.
Tnfaip3 knockout line. A pair of TALENs targeting zebrafish tnfaip3 (A20) exon 2 were generated using 
“PLATINUM Gate TALEN Kit” (Addgene, #1000000043). 0.2  ng of mRNA encoding the TALEN pair was 
delivered into the cytoplasm of wild-type zebrafish embryos at the one-cell stage. Founders were genotyped 
using the following primers: zfA20_Fw: AGT ATC TGC TGG GGG TTC AGGA and zfA20_Rev: CAC CGC ATG 
CAG AGCTT. Subsequently a founder line was identified harbouring a 20 bp deletion in exon 2 with a pre-
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dicted stop codon at amino acid 127. The tnfaip3dGI4 A20-deficient line was maintained in the heterozygous state 
 (tnfaip3∆127/tnfaip3+) and crossed to the zebrafish reporter lines described below.
Zebrafish reporter lines. The lck:RFP (TgBAC(lck:RFP)vcc4) and mpeg1.1:RFP (TgBAC(mpeg1.1:RFP)vcc7) 
reporter lines have been described previously. The lymphocyte protein tyrosine kinase (lck) promoter targets 
gene expression to T cells whereas macrophage expressed gene 1.1 (mpeg1.1) promoter targets gene expression to 
macrophages. The Tg(ins:dsRed)m1081;Tg(fabp10:dsRed;ela3l:GFP)gz12 line, known as 2-Color Liver Insulin aci-
nar Pancreas (2CLIP) fish line, has been described  previously62. This fish express dsRed fluorescent protein both 
in the hepatocytes, driven by the fatty acid binding protein 10 (fabp10 gene), and in the islets of the endocrine 
pancreas, driven by the insulin promoter (insulin gene). The exocrine pancreas instead expresses GFP driven 
by the pancreas specific transcriptor factor 1a (ptf1a gene). We generated the NF-κB reporter line Tg(NF-κB, 
c-FOS:EGFP)GI5 zebrafish line was generated using the Tol2 system to insert a DNA fragment containing six 
repeats of an NF-κB binding site in tandem with a minimal c-Fos promoter that drive the expression of EGFP, 
followed by an SV40 polyadenylation signal sequence (SV40pA), this construct has been previously  reported24.
Fluorescence quantification through ImageJ. Live zebrafish were placed in a gel solution (1 × E3 solu-
tion, 3% methyl cellulose, 5% Tricaine), in a 150 mm petri dish lid. Fish were placed on the left side up. Images 
were processed using ImageJ (v.1.50b). In the case of the NF-κB:EGFP line fluorescence measurements, an out-
line of the fish was drawn by hand, excluding the yolk sack due to its auto fluorescence. Measurement values of 
area (pixel/inch) and integrated density (area × mean grey value) were recorded for each of the measured fish. 
Background value was subtracted to the fish intensity value.
NF-κB and JNK reporter assays. The NF-κB reporter assay was conducted exactly as described 
 previously19. In brief, human Embryonic Kidney 293T (HEK293T)  cells63 were cultured in Dulbecco’s Modi-
fied Eagle’s  medium (DMEM) and incubated at 37  °C in 5%  CO2 and kept at a passage number between 
21–40 for experiments. Cells were transfected using Lipofectamine 2000 (ThermoScientific #11668019) with 
β-galactosidase (β-gal) and NF-κB.Luc with either ‘empty’ pcDNA3.1 vector (NTC; non template control) or 
pcDNA3.1 encoding wild-type human-A20 or either the A20 mutant Cys103Ala or Ser38Ala. HEK293T cells 
were stimulated with 300 U/ml of recombinant human TNFα (RandD Systems, Minneapolis, MN; #210-TA) 
for 8 h. To assess the effect of A20 mutants on JNK signalling, HEK293T cells which constitutively expresses 
mCherry Kinase Translocation Reporter (mCherryKTR) which translocates from the nucleus to the cytoplasm 
when phosphorylated by JNK were used (de la Cova, Townley et  al. 2017). JNK activity was determined by 
measuring the ratio between nucleus and cytoplasmic mCherry in cells transiently transfected with human-A20 
mutants (using JetPRIME reagent) following human TNFα stimulation. Each experiment included automated 
cell imaging (Thermo Scientific Cellomics Arrayscan machine) of ~ 150,000 to ~ 350,000 individual cells per well 
in duplicate wells over a period of 60 min (5 min intervals).
Generation of A20 mutants for ectopic expression in zebrafish. Three A20 mutants were generated 
for this study. Mutations were introduced into cDNA encoding full length human A20 by site directed mutagen-
esis to cause an alanine substitution at position Cys103 (C103A), a second clone at Ser381 (S381A) and a third 
clone a Tyrosine at position Cys243 (C243Y). Wild type A20 or mutant C103A, S381A or C243Y A20-cDNA 
were cloned into the expression cassette Ubb-[A20 insert]-P2A-EGFP and ~ 100 ng/μl of DNA was co-injected 
with I-SceI meganuclease to promote random integration in the zebrafish genome. Glass needles for zebrafish 
eggs injections were prepared from glass capillary tubes with filament (ø1 mm × 90 mm) (WPI #1B100F-3) using 
a NARISHIGE dual-stage micropipette puller PC-10 machine. The injections were all performed between the 
one and two-cell stage of development. The pUbb-hA20-P2A-EGFP was generated by modifying the published 
plasmid pUbb-iCre-EGFP64 in which iCre is fused to EGFP via a P2A sequence which sits downstream of the 
promoter of the zebrafish ubb gene. The entire cassette is flanked with with I-SceI (NEB, Ipswich, MA) sites. To 
generate pUbb-hA20-P2A-EGFP, iCre cDNA of pUbb-iCre-EGFP was replaced with hA20 cDNA using restric-
tion enzyme digest cloning, and the resultant plasmid was co-injected with I-SceI into one-cell-stage embryos.
Two-photon intravital microscopy. Two-photon imaging was performed using an upright Zeiss 7MP 
two-photon microscope (Carl Zeiss) with a W Plan-Apochromat 20 × /1.0 DIC (UV) Vis-IR water immersion 
objective. Four external NDDs were used to detect blue (SP 485), green (BP 500–550), red (BP 565–610) and far 
red (BP 640–710). High repetition rate femtosecond pulsed excitation was provided by a Chameleon Vision II 
Ti:Sa laser (Coherent Scientific) with 690–1064 nm tuning range. We acquired 3 μm z-steps at 512 × 512 pixels 
and resolution 0.83 μm/pixel at a frame rate of 10 fps and dwell time of 1.27 μs/pixel using bidirectional scan-
ning. Intravital two-photon microscopy was performed by embedding 1 wpf zebrafish in 1% low melting point 
agarose in E3 water and 0.4% Tricaine to limit the overall tissue drifting and motility of the fish.
Image processing and data analysis. Raw image files were processed using Imaris (Bitplane) software. 
A Gaussian filter was applied to reduce background noise. Tracking was performed using Imaris spot detection 
function to locate the centroid of cells. Motility parameters such as cell displacement (or track length calculated 
as the total length of displacements within the track) were obtained using Imaris Statistics function.
Statistical analysis. Data were analysed as appropriate using a nonparametric Mann–Whitney test, a 
Whelch t-test, Area under the curve (AUC) or a one-way ANOVA test. Statistical analyses were carried out 
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using GraphPad Prism v7.0. In all cases, the significance threshold was set at p ≤ 0.05. For clarity, only significant 
comparisons were reported on each graph.
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